Gastroparesis often causes symptoms such as the following: Stomach paralysis is more than fleeting discomfort
For patients seeking significant, sustained weight loss, GLP-1 efficacy substantially outpaces metformin monotherapy
Staying Safe While Finding Cheaper Options Cost-reduction efforts for GLP-1 medications must prioritize safety and regulatory compliance
After 24 weeks, mean decreases from baseline of -2.9% for A1C, -127 mg/dL for FPG, and -208 mg/dL for 2-hour PPG were observed
But coverage for semaglutides weight-loss formulation Wegovy may be more limited, depending on the insurance provider and plan
GLP-1 medications carry important warnings and contraindications, including a boxed warning for thyroid C-cell tumors in rodents (contraindicated in patients with personal/family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2)